Search research articles
Contact Us
Filters
Showing results (111-120 of 707) with videos related to
Page
of 71
Sort By:
Biological Psychiatry
|
December 4, 2012
Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review
Wayne C Drevets, Carlos A Zarate, Maura L Furey
Journal of Dairy Science
|
December 4, 2014
Effect of the dose of exogenous fibrolytic enzyme preparations on preingestive fiber hydrolysis, ruminal fermentation, and in vitro digestibility of bermudagrass haylage
J J Romero, M A Zarate, A T Adesogan
Current Psychosis & Therapeutics Reports
|
January 27, 2015
Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades
Rodrigo Machado-Vieira, Carlos A Zarate, Husseini K Manji
Drugs
|
June 27, 2012
Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date
Daniel C Mathews, Ioline D Henter, Carlos A Zarate
The Journal of Clinical Psychiatry
|
January 28, 2004
Glycogen synthase kinase-3: a target for novel bipolar disorder treatments
Todd D Gould, Carlos A Zarate, Husseini K Manji
Biological Psychiatry
|
February 5, 2013
Human biomarkers of rapid antidepressant effects
Carlos A Zarate, Daniel C Mathews, Maura L Furey
Archives of Pathology & Laboratory Medicine
|
August 1, 1992
Metastatic nasopharyngeal carcinoma initially presenting as cervical lymphadenopathy. A report of two cases that resembled Hodgkin's disease
A Zarate-Osorno, E S Jaffe, L J Medeiros
The Journal of Physiology
|
June 9, 2018
Effects of ketamine on the fetal transcriptomic response to umbilical cord occlusion: comparison with hypoxic hypoxia in the cerebral cortex
Miguel A Zarate, Eileen I Chang, Charles E Wood
Progress in Neurobiology
|
January 3, 2016
New targets for rapid antidepressant action
Rodrigo Machado-Vieira, Ioline D Henter, Carlos A Zarate
CNS Drugs
|
January 11, 2022
Authors' Reply to Pappagallo et al.: Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status"
Ioline D Henter, Lawrence T Park, Carlos A Zarate
Page
of 71
Search research articles
Search
Showing results (111-120 of 707) with videos related to
Sort By:
Page
of 71
Biological Psychiatry
|
December 4, 2012
Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review
Wayne C Drevets, Carlos A Zarate, Maura L Furey
Journal of Dairy Science
|
December 4, 2014
Effect of the dose of exogenous fibrolytic enzyme preparations on preingestive fiber hydrolysis, ruminal fermentation, and in vitro digestibility of bermudagrass haylage
J J Romero, M A Zarate, A T Adesogan
Current Psychosis & Therapeutics Reports
|
January 27, 2015
Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades
Rodrigo Machado-Vieira, Carlos A Zarate, Husseini K Manji
Drugs
|
June 27, 2012
Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date
Daniel C Mathews, Ioline D Henter, Carlos A Zarate
The Journal of Clinical Psychiatry
|
January 28, 2004
Glycogen synthase kinase-3: a target for novel bipolar disorder treatments
Todd D Gould, Carlos A Zarate, Husseini K Manji
Biological Psychiatry
|
February 5, 2013
Human biomarkers of rapid antidepressant effects
Carlos A Zarate, Daniel C Mathews, Maura L Furey
Archives of Pathology & Laboratory Medicine
|
August 1, 1992
Metastatic nasopharyngeal carcinoma initially presenting as cervical lymphadenopathy. A report of two cases that resembled Hodgkin's disease
A Zarate-Osorno, E S Jaffe, L J Medeiros
The Journal of Physiology
|
June 9, 2018
Effects of ketamine on the fetal transcriptomic response to umbilical cord occlusion: comparison with hypoxic hypoxia in the cerebral cortex
Miguel A Zarate, Eileen I Chang, Charles E Wood
Progress in Neurobiology
|
January 3, 2016
New targets for rapid antidepressant action
Rodrigo Machado-Vieira, Ioline D Henter, Carlos A Zarate
CNS Drugs
|
January 11, 2022
Authors' Reply to Pappagallo et al.: Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status"
Ioline D Henter, Lawrence T Park, Carlos A Zarate
Page
of 71